Market Tracker

09/19 6:35pm ET

Novo Nordisk A/S (NYSE:NVO)

48.41
Data as of Sep 19
 -0.62 / -1.26%
Today’s Change
32.55
Today|||52-Week Range
49.11
+31.01%
Year-to-Date

Today’s Trading

Previous close49.03
Today’s open48.61
Day’s range48.39 - 48.79
Volume1,214,773
Average volume (3 months)958,587
Market cap$100.6B
Dividend yield1.72%
Data as of 4:02pm ET, 09/19/2014

Growth & Valuation

Earnings growth (last year)+23.61%
Earnings growth (this year)--
Earnings growth (next 5 years)+11.15%
Revenue growth (last year)+10.11%
P/E ratio--
Price/Sales6.64
Price/Book16.30

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca PLC+0.56+0.76%
ABBVAbbVie Inc-0.39-0.66%
GSKGlaxoSmithKline PLC+0.09+0.19%
BMYBristol-Myers Squibb...+0.39+0.76%
Data as of 4:04pm ET, 09/19/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)$0.45
Annual revenue (last year)$14.9B
Annual profit (last year)$4.5B
Net profit margin30.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
President &
Chief Operating Officer
Kåre Schultz
Corporate headquarters
Bagsvrd, --

Forecasts